CMS Sets Higher Reimbursement Rates For 3D Mammography

Hologic has struggled to gain market acceptance of its 3D breast tomosynthesis technologies because of the lack of reimbursement. But CMS has now delivered a long-awaited surplus rate for 3D compared to 2D scans, which is expected to boost adoption.